Followers | 261 |
Posts | 33711 |
Boards Moderated | 2 |
Alias Born | 01/24/2013 |
Thursday, October 12, 2023 3:44:09 PM
A sure sign that the debate has been won:
When the response is an attack against the other person.
Recent OMGA News
- Omega Therapeutics Announces Publication of Epigenomic Controller OTX-2002 Preclinical Data in Nature Communications • GlobeNewswire Inc. • 09/17/2024 11:00:02 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/30/2024 08:01:07 PM
- Omega Therapeutics Announces Jennifer Nelson, Ph.D., as Senior Vice President of Research • GlobeNewswire Inc. • 08/14/2024 11:00:08 AM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/06/2024 11:03:38 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/06/2024 11:02:33 AM
- Omega Therapeutics Reports Second Quarter 2024 Financial Results and Highlights Recent Company Progress • GlobeNewswire Inc. • 08/06/2024 11:00:09 AM
- Flagship Pioneering Announces Appointment of Raj Panjabi as Senior Partner • PR Newswire (US) • 08/06/2024 10:30:00 AM
- Omega Therapeutics Announces Election of Richard N. Kender to Board of Directors • GlobeNewswire Inc. • 06/24/2024 11:00:53 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/31/2024 08:57:45 PM
- Form 8-K/A - Current report: [Amend] • Edgar (US Regulatory) • 05/30/2024 09:10:10 PM
- Omega Therapeutics To Participate In Two Upcoming Investor Conferences • GlobeNewswire Inc. • 05/30/2024 11:00:59 AM
- Omega Therapeutics Appoints Kaan Certel, Ph.D., as Chief Business Officer • GlobeNewswire Inc. • 05/29/2024 11:00:17 AM
- Omega Therapeutics Presents New Preclinical Data at ASGCT 2024 Demonstrating Tunable and Durable Upregulation of Gene Expression with Epigenomic Controllers • GlobeNewswire Inc. • 05/08/2024 11:00:00 AM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/06/2024 11:06:23 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/06/2024 11:04:21 AM
- Omega Therapeutics Reports First Quarter 2024 Financial Results and Highlights Recent Company Progress • GlobeNewswire Inc. • 05/06/2024 11:00:02 AM
- Omega Therapeutics to Present New Preclinical Data on Epigenomic Upregulation at the American Society of Gene and Cell Therapy 27th Annual Meeting • GlobeNewswire Inc. • 04/23/2024 11:00:02 AM
- Omega Therapeutics Presents New Preclinical Data at AACR 2024 Supporting the Potential of Precision Epigenomic Control • GlobeNewswire Inc. • 04/09/2024 11:00:31 AM
- Omega Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Strategic Update • GlobeNewswire Inc. • 03/28/2024 01:15:05 PM
- Omega Therapeutics Announces Two Poster Presentations at the American Association for Cancer Research Annual Meeting 2024 • GlobeNewswire Inc. • 03/06/2024 12:00:08 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/09/2024 10:14:52 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/09/2024 10:00:33 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/09/2024 09:59:27 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/05/2024 09:00:18 PM
- Omega Therapeutics to Present at the 42nd Annual J.P. Morgan Healthcare Conference • GlobeNewswire Inc. • 01/02/2024 09:05:13 PM
Lingerie Fighting Championships Signs Broadcast Deal With Maybacks Global Entertainment • BOTY • Sep 26, 2024 9:00 AM
Maybacks Global Entertainment and Lingerie Fighting Championships Enter Into Broadcast And Revenue Sharing Agreement • AHRO • Sep 26, 2024 8:30 AM
North Bay Resources Commences Operations at Bishop Gold Mill, Inyo County, California; Engages Sabean Group Management Consulting • NBRI • Sep 25, 2024 9:15 AM
CEO David B. Dorwart Anticipates a Bright Future at Good Gaming Inc. Through His Most Recent Shareholder Update • GMER • Sep 25, 2024 8:30 AM
Cannabix Technologies and Omega Laboratories Inc. Advance Marijuana Breathalyzer Technology - Dr. Bruce Goldberger to Present at Society of Forensic Toxicologists Conference • BLOZF • Sep 24, 2024 8:50 AM
Integrated Ventures, Inc Announces Strategic Partnership For GLP-1 (Semaglutide) Procurement Through MedWell USA, LLC. • INTV • Sep 24, 2024 8:45 AM